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ABSTRACT Globally, more antimicrobials are used in food-producing animals than in
humans, and the extensive use of medically important human antimicrobials poses a
significant public health threat in the face of rising antimicrobial resistance (AMR). The
development of novel ionophores, a class of antimicrobials used exclusively in animals,
holds promise as a strategy to replace or reduce essential human antimicrobials in veter-
inary practice. PBT2 is a zinc ionophore with recently demonstrated antibacterial activity
against several Gram-positive pathogens, although the underlying mechanism of action
is unknown. Here, we investigated the bactericidal mechanism of PBT2 in the bovine
mastitis-causing pathogen, Streptococcus uberis. In this work, we show that PBT2 func-
tions as a Zn2/H ionophore, exchanging extracellular zinc for intracellular protons in
an electroneutral process that leads to cellular zinc accumulation. Zinc accumulation
occurs concomitantly with manganese depletion and the production of reactive oxy-
gen species (ROS). PBT2 inhibits the activity of the manganese-dependent super-
oxide dismutase, SodA, thereby impairing oxidative stress protection. We pro-
pose that PBT2-mediated intracellular zinc toxicity in S. uberis leads to lethality
through multiple bactericidal mechanisms: the production of toxic ROS and the impair-
ment of manganese-dependent antioxidant functions. Collectively, these data show that
PBT2 represents a new class of antibacterial ionophores capable of targeting bacterial
metal ion homeostasis and cellular redox balance. We propose that this novel and multi-
target mechanism of PBT2 makes the development of cross-resistance to medically im-
portant antimicrobials unlikely.
IMPORTANCE More antimicrobials are used in food-producing animals than in hu-
mans, and the extensive use of medically important human antimicrobials poses a sig-
nificant public health threat in the face of rising antimicrobial resistance. Therefore, the
elimination of antimicrobial crossover between human and veterinary medicine is of
great interest. Unfortunately, the development of new antimicrobials is an expensive
high-risk process fraught with difficulties. The repurposing of chemical agents provides a
solution to this problem, and while many have not been originally developed as antimi-
crobials, they have been proven safe in clinical trials. PBT2, a zinc ionophore, is an exper-
imental therapeutic that met safety criteria but failed efficacy checkpoints against both
Alzheimer’s and Huntington’s diseases. It was recently found that PBT2 possessed potent
antimicrobial activity, although the mechanism of bacterial cell death is unresolved. In
this body of work, we show that PBT2 has multiple mechanisms of antimicrobial action,
making the development of PBT2 resistance unlikely.
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The widespread emergence of antimicrobial resistance (AMR) threatens the securityof modern medicine. Antimicrobial use in food-producing animals is recognized as
an important driver of AMR, raising concerns in light of the considerable overlap of
antimicrobials used in both humans and animals (1). With food consumption rising to
meet the demands of a growing global population, antimicrobial use in food-producing
animals is consequently set to increase (2). This intensification of antimicrobial use
comes with a greater risk of resistance emerging (3, 4) and warrants the elimination of
antimicrobial crossover between human and veterinary medicine.
Bovine mastitis, an inflammatory disease of the bovine mammary gland, is the
leading cause for antimicrobial use in the dairy industry worldwide (5, 6). The Gram-
positive pathogen Streptococcus uberis is a common environmental cause of bovine
mastitis (7). Due to the ubiquity of environmental pathogens such as S. uberis in the
dairy environment, prevention of environmental mastitis is particularly challenging and
relies heavily on antimicrobial sanitizers (8, 9). Chlorhexidine and iodine, which the
World Health Organization (WHO) recognizes as essential antiseptics for human med-
icine (10), are among the most common antiseptics used in teat disinfectants (11).
Increased tolerance to chlorhexidine has been reported in both Gram-positive and
Gram-negative hospital-associated pathogens (12–14), illustrating the pressing need to
discover novel animal-only antimicrobials for mastitis prevention and treatment.
Ionophores represent a class of molecules capable of binding and transporting
protons or other cations across biological membranes (15). With the exception of the
mycobactericidal drug bedaquiline, with recently demonstrated H/K ionophoric
activity (16), ionophoric drugs (e.g., monensin, lasalocid, salinomycin, and narasin) are
exclusively used in agriculture (17). Despite the routine use of ionophores in agriculture
for more than 35 years, there is little indication of increasing resistance to these drugs
or of cross-resistance to medically important classes of antimicrobials (17). Developing
novel antimicrobials with ionophoric mechanisms of action for veterinary-only medi-
cine satisfies the requirement for antimicrobials in food-producing animals without
risking crossover with human medicine.
PBT2, a derivative of the 8-hydroxyquinoline (8-HQ) scaffold, has been demonstrated
to act as a zinc and copper ionophore in mammalian cells (18). PBT2 facilitates the
intracellular accumulation of these metals and showed promise as a therapeutic for
targeting the abnormal metallochemistry in Alzheimer’s and Huntington’s diseases (18,
19). In phase II clinical trials, however, efficacy endpoint criteria were not met in
PBT2-treated patients with these neurodegenerative diseases (20–22). Despite this,
extensive preclinical and clinical data demonstrate PBT2 is safe and well tolerated in
humans and in animal (mouse) models (20–22).
In bacterial cells, zinc is an essential micronutrient for normal physiology yet can
mediate significant toxicity in excess (23, 24). The essentiality and toxicity of zinc in
bacterial pathogens has been exploited by host defense mechanisms that starve cells
of zinc, in a concept termed “nutritional immunity” (25, 26), or deliver the metal in
excess toxic quantities (27, 28). Given the vulnerability of bacterial cells to zinc stress
and the safety profile of PBT2 in mammalian hosts, the antimicrobial potential of this
zinc ionophore was recently investigated. Indeed, PBT2 in combination with zinc
(PBT2-zinc) has potent antibacterial activity against multiple Gram-positive pathogens
(29). Antibacterial activity was observed in vitro and in vivo in a murine wound infection
model, highlighting the potential of PBT2 to be repurposed as a topical antimicrobial
in veterinary medicine (29).
While PBT2 was shown to increase cytosolic zinc and disrupt metal ion homeostasis
in bacteria (29), a defined molecular mechanism of killing remained unresolved and is
key to the development of effective next-generation derivatives. In this study, we show
that PBT2 is a Zn2/H ionophore and exerts bactericidal activity in S. uberis through
intracellular zinc toxicity, which leads to the accumulation of toxic reactive oxygen
species (ROS) and dysregulates manganese homeostasis, causing cells to become
hypersensitive to oxidative stress. Our work builds on the current knowledge of the
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coordinated relationship between zinc and manganese in bacteria and illustrates how
it can be exploited for antimicrobial potential.
RESULTS
PBT2 and zinc exhibit antibacterial synergy. We examined if the reported anti-
bacterial activity of PBT2 extended to the bovine pathogen S. uberis. A checkerboard
assay was undertaken to determine the MIC and combined inhibitory concentrations
(CICs) of PBT2 and zinc. Both PBT2 and zinc individually displayed antibacterial activity
against S. uberis, with MICs of 5.0 mg/liter (14.5 M) and 800 M, respectively (Table S1;
see also Fig. S1 in the supplemental material). Combining PBT2 and zinc dramatically
increased the antibacterial effectiveness of both compounds, with a CIC of 0.5 mg/liter
PBT2 (1.45 M) in the presence of 10 M zinc or 0.05 mg/liter PBT2 (0.145 M) with
100 M zinc. The fractional inhibitory concentration indexes (FICIs) of 0.113 and 0.135
indicate PBT2 and zinc interact synergistically (FICI  0.5). A time-dependent cell-killing
assay revealed 3-log10 reductions in CFU/ml of initial inocula following treatment
with the MIC of either PBT2 or zinc, indicating a bactericidal mechanism of action
(Fig. 1A). The observed bactericidal activity of PBT2 alone may be attributable to the
concentration of 23 M zinc in the growth medium, Todd-Hewitt broth (THB), which
was determined by inductively coupled plasma mass spectrometry (ICP-MS). However,
the extent to which PBT2 mobilizes the bioavailable proportion of medium zinc was not
determined. Remarkably, treatment with the CIC of PBT2 and zinc (PBT2Zn) was
bactericidal, even at 10-fold and 80-fold lower concentrations of PBT2 and zinc MICs,
respectively (Fig. 1A).
We next sought to compare the ability of S. uberis to develop resistance to PBT2Zn
and two medically important antibiotics, rifampin and the fluoroquinolone antibiotic
ciprofloxacin, by serial passaging through progressively increasing drug concentrations
over a course of 30 days. While the ciprofloxacin and rifampin MICs increased by 72-fold
and 4,608-fold, respectively, the PBT2Zn MIC increased by only 4-fold (Fig. 1B).
Because antimicrobial activity can be negatively affected by proteins and lipids
present in milk (30), assessing the antimicrobial efficacy in bovine milk is important for
the development of potential new therapeutics for mastitis prevention or treatment.
We tested the bactericidal efficacy of PBT2Zn in whole cow’s milk and observed that
PBT2 remained bactericidal against S. uberis (MBCs of 32 mg/liter for PBT2  0 M Zn,
16 mg/liter for PBT2  200 M Zn, and 8 mg/liter for PBT2  400 M Zn).
PBT2-zinc disrupts metal ion homeostasis. ICP-MS analysis was used to determine
the metal ion content of S. uberis cells in response to PBT2 treatment. Consistent with
the ionophore activity of PBT2, a concentration-dependent increase in whole-cell zinc
accumulation was observed in response to increasing concentrations of PBT2 (Fig. 2A).
FIG 1 Bactericidal action and resistance development of PBT2 and zinc against S. uberis. (A) Time-
dependent cell killing of S. uberis in response to MICs of PBT2 and zinc, alone (5.0 mg/liter PBT2, 800 M
zinc) and in combination (0.5 mg/liter PBT2  10 M zinc). THB contains a background concentration of
23 M zinc. Error bars represent the standard deviations of the means from biological triplicates. (B)
Development of resistance to PBT2Zn compared to that for rifampin and ciprofloxacin. S. uberis was
serially passaged for 30 days in the presence of subinhibitory concentrations of PBT2 (100 M Zn),
rifampin, or ciprofloxacin in THB. Data represent the means from two biological replicates.
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While 0.25 mg/liter PBT2 alone had no effect on cellular zinc abundance, in the
presence of zinc (100 M), cells treated with 0.25 mg/liter PBT2 accumulated 3-fold
more zinc than untreated cells (P  0.006) (Fig. 2A). Additional PBT2 did not increase
cellular zinc further, with zinc plateauing at a similar level to that in cells treated with
the highest tested concentration of PBT2 alone (1.0 mg/liter) (Fig. 2A). This suggests
zinc accumulated by higher concentrations of PBT2 may exceed tolerated cellular levels
and either induces mechanisms to maintain zinc homeostasis or causes cell death.
Previous evidence in mammalian cell models indicates that PBT2 acts as both a zinc and
copper ionophore (18). However, there were no observable changes in S. uberis copper
levels in response to PBT2 treatment (Fig. 2B). This is likely attributable to the low
concentration of copper (1 M) in the growth medium relative to that of zinc (23 M).
We speculate that under our experimental conditions, zinc outcompetes copper for
chelation to PBT2.
Treatment with PBT2 and zinc altered the cellular abundances of manganese and
iron (Fig. 2C and D). Manganese levels decreased by up to 7.5-fold in response to
PBT2-zinc challenge (P  0.0001) compared to those in untreated cells (Fig. 2C).
Decreased manganese levels were also observed in cells treated with either PBT2 or
zinc alone (Fig. 2C). Exogenous zinc was previously reported to deplete cellular man-
ganese in Streptococcus pneumoniae, causing cells to become hypersensitive to oxida-
tive stress (27, 31). In response to oxidative stress, streptococci restrict cellular iron
levels as a strategy to limit the generation of ROS through iron-mediated Fenton
chemistry (32–34). Similarly, S. uberis treated with either PBT2 (0.5 and 1.0 mg/liter) or
zinc had significantly lower cellular iron than untreated cells (P  0.0387, 0.0335, and
0.0498, respectively) (Fig. 2D). Collectively, these data suggest that PBT2-mediated zinc
FIG 2 PBT2-zinc alters intracellular metal ion homeostasis. Intracellular zinc (A), copper (B), manganese
(C), and iron (D) concentrations as determined by ICP-MS of mid-log-phase S. uberis NZ01 cells (OD600 of
0.3) treated with various concentrations of PBT2 with or without additional zinc (100 M) or untreated.
Error bars represent the standard deviations of the means from biological triplicates. *, P  0.05; **, P 
0.005; ***, P  0.001; ****, P  0.0001 by one-way analysis of variance (ANOVA).
Harbison-Price et al.
March/April 2020 Volume 5 Issue 2 e00157-20 msphere.asm.org 4
 on M




























accumulation perturbs normal metal ion homeostasis and may sensitize cells to oxi-
dative stress.
PBT2 exchanges zinc ions for protons. Ionophores are compounds with the ability
to translocate cations, protons, or both and are therefore capable of dissipating either
the membrane potential (Δ) (e.g., valinomycin) or transmembrane pH gradient (ΔpH)
(e.g., nigericin) components of the proton motive force (PMF) (15). To examine if the
bactericidal mechanism of PBT2 is explained by dissipation of the PMF, we measured
the Δ and ΔpH of S. uberis cells in response to PBT2-zinc by using the radioisotopes
[14C]methyltriphenyl phosphonium iodide ([14C]TPP) and [7-14C]benzoate, respec-
tively. No observable differences in either component of the PMF occurred in response
to treatment with PBT2-zinc at either 1 or 10 the CIC (0.5 mg/liter PBT2  10 M
zinc) (see Fig. S2).
As we observed an increase in cellular zinc, but no effect on the membrane potential
of whole cells (Fig. S2C), we hypothesized that a counterion (either protons or other
cations) might be moved to make the process electroneutral. To test this, we assessed
the ability of PBT2 to move protons in phosphatidylcholine liposomes loaded with the
non-membrane-permeable and pH-sensitive probe, pyranine (Fig. 3). Pyranine-
containing liposomes have previously been used as a controlled system for measuring
internal pH changes in response to protonophoric or ionophoric drugs (16, 35) where
finite, (electro)chemical gradients are artificially established and used to assess proton
movement across artificial lipid bilayers. Changes in the liposome luminal pH (internal
pH) are detected by measuring the fluorescence of the acidic and basic forms of
pyranine, the ratio of which is dependent on pH (Fig. 3A).
In response to external zinc addition, PBT2 was able to cause a concomitant increase
(alkalization) of the liposome internal pH (Fig. 3B and C and Fig. S3). As PBT2-zinc does
not alter the cell membrane permeability of group A Streptococcus (GAS), vancomycin-
resistant Enterococcus (VRE), or methicillin-resistant Staphylococcus aureus (MRSA) (29),
we attribute this effect to a direct interaction of PBT2 with protons rather than proton
leakage through damaged liposomal membranes. This effect was not observed in the
absence of zinc (see Fig. S4), suggesting it is dependent on the formation of a PBT2-zinc
complex. Using isothermal titration calorimetry (ITC), we confirmed the formation of 2:1
PBT2-Zn complexes, as previously observed (see Fig. S5) (36). Collectively this suggests
PBT2 exchanges zinc for protons in an antiport-like process. Inverting the gradient, by
incorporating zinc inside the liposome during preparation, resulted in a concomitant
internal acidification upon PBT2 addition (Fig. 3C and Fig. S6). This suggests the process
is not direction specific and is driven purely by the Zn2 concentration gradient.
Notably, acidification of the assay buffer to pH 6.5 enhanced this antiport activity up to
7.5-fold, compared to that at pH 8.5 (Fig. 3B and C and Fig. S3). Given the apparent
absence of a biological effect from PBT2-mediated proton translocation, we continued
this work with a focus on the consequences of zinc delivery into cells by PBT2.
PBT2-zinc induces transcriptional changes to metal ion transporter genes. To
further understand the effect of PBT2 and zinc on metal ion homeostasis, changes in
the expression of genes involved in metal ion transport were investigated. Consistent
with the observed changes in metal ion levels, several metal ion transporters were
differentially expressed in response to PBT2-zinc challenge (Fig. 4). S. uberis contains the
ATP-binding cassette (ABC) permease AdcABC, a conserved zinc acquisition system
among streptococci (37). We observed that the zinc-specific solute binding protein
(SBP), adcA (CGZ53_03345), was downregulated 4.5 log2-fold in response to PBT2-
zinc (Fig. 4). Consistent with previous work on cadA homologs demonstrating
function in zinc export, S. uberis cadA (CGZ53_06375) was upregulated 3.7 log2-fold
in response to PBT2-zinc (Fig. 4). In another demonstration of increased zinc export
in response to PBT2-zinc, expression of a putative homolog of the czcD zinc efflux
pump (CGZ53_05790) increased 1.8 log2-fold (Fig. 4).
S. uberis contains a homolog of the S. pneumoniae PsaABC manganese importer,
termed MtuABC, with an established role in manganese uptake (38). Consistent with
Bactericidal Mechanism of the Zinc Ionophore PBT2
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the observed depletion in manganese upon PBT2-zinc treatment (Fig. 2C), transcrip-
tional profiling revealed that mtuA (CGZ53_02610) was strongly downregulated (3.5
log2-fold) in response to PBT2-zinc treatment (Fig. 4). The upregulation of fetB, a
putative iron export ABC transporter permease, following PBT2-zinc treatment, to-
gether with our previous finding of decreased cellular iron in PBT2-zinc treated wild-
type cells (Fig. 4 and 2D), supports the inference that cells must tightly regulate iron to
avoid iron toxicity under conditions where antioxidative mechanisms are compromised.
PBT2-mediated zinc toxicity sensitizes cells to killing by ROS. If excess zinc in S.
uberis exerts toxicity through manganese starvation, as previously observed in S.
pneumoniae (27), then supplementing cells with manganese should rescue the ob-
served lethality associated with PBT2-zinc treatment. We found cultures pretreated with
manganese (800 M) were completely protected against cell killing by PBT2, zinc, and




































































FIG 3 PBT2 is a Zn2/H ionophore. (A) Schematic for measuring internal pH using pyranine-containing
liposomes: pyranine is a non-membrane-permeable pH indicator where the ratio of the acidic to basic
forms of pyranine is pH dependent. Excitation of acidic (ex 405 nm) and basic (ex 455 nm) pyranine
generates detectable fluorescence (em 510 nm). The internal pH of liposomes equilibrates over time with
the external pH, and internal pH can be determined using a standard curve of pH to pyranine
fluorescence ratios. In these experiments, pyranine fluorescence was measured and internal pH was
determined after addition of PBT2 and/or zinc to liposomes from a 15-min endpoint. Changes to internal
pH by PBT2-zinc were normalized for the effect of external zinc (103 M) alone. (B) Changes in internal
pH of pyranine-containing liposomes with matching internal and external pH values following addition
of PBT2 (106 M) in combination with zinc (103 M). (C) Relative changes in internal pHs of liposomes
suspended in Mes-Mops-Tris buffer (pH indicated) containing PBT2 (106, 107, or 108 M), where zinc
(103 M) is either external to liposomes (plain bars) or internal (striped bars). Error bars represent the
standard deviations from triplicate measurements.
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Manganese has prominent roles in oxidative stress protection in biological systems,
from serving as a cofactor for manganese-dependent superoxide dismutase to forming
ROS-scavenging Mn-organic acid complexes (39–41). As in related streptococcal species
(31, 33), S. uberis relies solely on a manganese-dependent superoxide dismutase (SodA)
for the conversion of accumulated O2· to H2O2 and O2. To determine if oxidative stress
contributes to the lethality of PBT2 and zinc, we tested whether an antioxidant could
FIG 4 PBT2-zinc alters the expression of metal ion transport genes. Relative expression of selected genes
in mid-log-phase S. uberis cells (OD600 of 0.3) after 1 h of treatment with or without PBT2 (1.0 mg/liter)
and zinc (100 M), individually or in combination. Relative expression (expressed as log2-fold change)
was calculated relative to the untreated control and normalized to the reference gene (pflC) using the
CT method. Error bars represent the standard deviations of the means from biological triplicates.
FIG 5 Manganese and reduced glutathione (GSH) protect against PBT2-zinc killing. Pretreatment of S. uberis cells (OD600 of
0.05) with manganese or GSH before the addition of PBT2 (A), zinc (B), or PBT2Zn (C) at respective MICs and CICs prevents
cell killing. Error bars represent the standard deviations of the mean from biological triplicates.
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prevent cell killing. Pretreatment with reduced glutathione (GSH) (50 mM) added
extracellularly, an antioxidant capable of neutralizing ROS in bacteria (42), provided
protection against the bactericidal action of PBT2 and zinc (Fig. 5A to C). Because zinc
is able to bind to the sulfhydryl group of the GSH cysteine moiety and form GSH-Zn
complexes (43), which may explain the observed protective effect of GSH, we under-
took further experimentation to clarify the role of oxidative stress in the PBT2-zinc
bactericidal mechanism.
We hypothesized that by depleting intracellular manganese, PBT2-zinc would inhibit
SodA enzyme activity. As anticipated, cultures treated with PBT2-zinc showed a 2.7-fold
reduction in SodA activity compared to that in untreated cells (P  0.0156) (Fig. 6A).
Treatment with PBT2 alone reduced SodA activity by 2.6-fold (P  0.0179), but zinc
alone had no effect (Fig. 6A). Transcriptional profiling of sodA revealed no changes in
expression following PBT2, zinc, or PBT2-zinc treatment, suggesting PBT2 does not
interfere with normal sodA regulation (see Fig. S7). Provision of excess exogenous
manganese significantly increased the SodA activity (P  0.0041), and when in com-
bination with PBT2-zinc, manganese partially restored SodA function (P  0.0345)
(Fig. 6A).
To examine if ROS accumulate as a consequence of PBT2-mediated zinc toxicity and
manganese starvation, we specifically measured the production of H2O2. We found that
PBT2 or zinc alone had no effect on H2O2 levels compared to that in untreated cells
(Fig. 6B). However, cells treated with PBT2-zinc showed increased H2O2 (P  0.0380)
(Fig. 6B). S. uberis harbors an alkyl hydroperoxidase (ahpC and ahpF) for the detoxifi-
cation of H2O2, yet no changes in expression of either ahpC or ahpF were observed in
response to PBT2-zinc (Fig. S7). As a critical test of the hypothesis that manganese
abolishes PBT2-zinc lethality by restoring antioxidant function, we examined the effect
of manganese on H2O2 production. The addition of exogenous manganese to PBT2-
zinc-treated cells dramatically increased detectable H2O2 (P  0.0001) (Fig. 6B). This
finding supports the notion that providing excess manganese enables the sole super-
oxide dismutase, the manganese-dependent SodA, to convert accumulated O2· to
H2O2 and O2, ultimately increasing detectable H2O2. Treatment with manganese alone
also demonstrated an increase in H2O2, although this was not statistically significant
(P  0.4742) (Fig. 6B). This supports an increased rate of O2· turnover through SodA
by provision of excess amounts of the manganese cofactor.
FIG 6 PBT2-zinc impairs SodA activity and generates ROS. (A) Superoxide dismutase (SOD) activity
of mid-log-phase S. uberis cells (OD600 of 0.3) treated with PBT2 (1.0 mg/liter), zinc (100 M), or
manganese (800 M), individually or in combination. Cell lysates were analyzed for SOD activity and
normalized for total protein. (B) H2O2 generation of mid-log-phase S. uberis cells (OD600 of 0.3)
treated with PBT2 (1.0 mg/liter), zinc (100 M), or manganese (800 M), individually or in combina-
tion, as detected by Amplex Red fluorescence (560 ex, 590 em). Untreated and H2O2-treated
controls are included for comparison. Error bars represent the standard deviations of the means from
biological triplicates. ns, P  0.05; *, P  0.05; **, P  0.005; ***, P  0.001; ****, P  0.0001 by
one-way ANOVA.
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In this work, we show that the bactericidal mechanism of PBT2 is mediated by
intracellular zinc toxicity, which disrupts manganese homeostasis and leads to the
accumulation of toxic ROS. In this global bactericidal mechanism of action, S. uberis was
unable to generate significant resistance to PBT2Zn in comparison to the single-
target antibiotics ciprofloxacin (44) and rifampin (45). In addition, this work provides a
molecular mechanism for PBT2 ionophoric activity in bacterial cells, whereby PBT2
translocates across the bacterial cell membrane acting as a Zn2/H ionophore. The
absence of an effect on the membrane potential indicates PBT2 functions as an
electroneutral ionophore, in support of an exchange of one Zn2 ion for two H ions.
While there was a pronounced alkalization of pyranine-containing liposomes from
PBT2-mediated proton translocation, no changes in internal pH were found in whole
cells. Bacterial cells employ multiple homeostatic mechanisms to maintain intracellular
pH in a narrow tolerable range (46), and such regulatory mechanisms likely protect cells
from intracellular pH alterations by PBT2.
We observed an enhancement of PBT2 ionophoric activity at lower pH, suggesting
that protonation of PBT2 is required for efficient zinc transport. A detailed structural
analysis by Nguyen et al. (36) has revealed zinc chelation by PBT2 occurs through the
pyridine nitrogen and deprotonated phenoxide. Protonation of the PBT2-zinc complex
at low pH may therefore promote the release of zinc according to the membrane
potential and zinc concentration gradient. Given that cytosolic “free” zinc in bacterial
cells is in the picomolar to nanomolar range (47) and PBT2 binds zinc with an affinity
of 	2 M, it is unlikely PBT2 is capable of moving zinc ions out of bacterial cells.
Collectively, these data, along with the finding of PBT2-mediated zinc accumulation,
provide a novel molecular model for PBT2 ionophoric activity in which PBT2 exchanges
extracellular zinc for intracellular protons in an electroneutral process (Fig. 7).
Similar to previous work investigating zinc toxicity in S. pneumoniae (27, 31, 48), we
show exogenous zinc significantly depletes cellular manganese in S. uberis. Consis-
tently, addition of manganese (800 M) protects against zinc toxicity. In these previous
studies, the proposed mechanism of zinc-mediated manganese starvation is through
zinc competitively binding to the extracellular PsaA, the manganese SBP of the PsaABC
manganese importer, thereby limiting manganese uptake. Given the identical compo-
sitions of the metal-binding sites in the S. uberis PsaA homolog (MtuA) and S. pneu-
moniae PsaA (38), zinc may similarly impede manganese import in S. uberis by mis-
metallation of MtuA. While this may be the case under conditions of excess exogenous
zinc, manganese depletion occurred concomitantly with PBT2-mediated intracellular
zinc accumulation. This indicates the existence of an alternative mechanism whereby
intracellular zinc intoxication interferes with normal manganese homeostasis. The
depletion of mtuA transcripts following PBT2-zinc treatment indicates excess intracel-
lular zinc dysregulates mtuA expression, thereby preventing manganese import. Con-
sistently, Bohlmann et al. (29) found that expression of the GAS mtuA homolog (mtsA)
is reduced 2.3 log2-fold in response to PBT2-zinc. The molecular target of this zinc
mismetallation was not identified in our study; however, mismetallation of metallo-
regulators, which sense specific metal ions and modulate transcription of regulated
genes in accordance with physiological needs, was previously observed under condi-
tions of cytosolic metal intoxication (49). In Bacillus subtilis, intracellular zinc intoxication
leads to mismetallation of the peroxide response regulator PerR, which, when bound to
zinc, cannot repress heme biosynthesis and consequently leads to toxic heme accu-
mulation (50). Similarly, under conditions of manganese intoxication, the ferric uptake
regulator Fur is mismetallated with manganese and inappropriately represses iron
uptake (51).
Given that exogenous zinc (100 M) does not affect intracellular zinc content nor
SodA activity yet depletes manganese to similar levels as PBT2 alone, PBT2-mediated
zinc accumulation may inhibit SodA function through zinc mismetallation. Reduced
SodA activity as a result of the zinc ionophoric activity of PBT2 may therefore result
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from a combination of depletion of the essential manganese cofactor and mismetal-
lation of SodA with zinc. Mismetallation of the GAS SodA with iron reduces the enzyme
activity (33); however, investigations into the functionality of the Zn-SodA enzyme are
lacking.
The accumulation of H2O2 in PBT2-zinc-treated cells indicates a bactericidal mech-
anism whereby intracellular zinc intoxication leads to the generation of ROS, in addition
to impairing the ability to manage oxidative stress. Zinc lacks biological redox activity
but may perturb the intracellular redox status indirectly through protein mismetallation
and inactivation. Indeed, heme accumulation following zinc mismetallation of PerR
causes toxic superoxide generation as a result of redox cycling between heme and
menaquinone (50). Because the provision of manganese to PBT2-zinc-treated cells
increased cellular H2O2, we infer that intracellular zinc intoxication accumulates O2· in
addition to H2O2. In addition to providing protection against O2·, manganese can
catalytically scavenge H2O2 and replace iron in the active sites of iron-containing
enzymes, thereby preventing iron oxidation by H2O2 and subsequent protein inactiva-
tion (52, 53). Our data suggest that providing sufficient manganese restores the activity
of Mn-SodA and nonenzymatic manganese-based antioxidants that scavenge ROS,
thereby reestablishing redox balance under conditions of zinc toxicity.
We propose a model for the bactericidal mechanism of action of the zinc ionophore
PBT2 (Fig. 7): PBT2 binds extracellular zinc as a complex and dissociates in the
cytoplasm, releasing zinc in exchange for intracellular protons in an electroneutral
process that leads to cellular zinc accumulation. Excess intracellular zinc perturbs
normal metal ion homeostasis and dysregulates the expression of mtuABC, causing
manganese depletion. Zinc intoxication additionally disrupts the intracellular redox
FIG 7 Proposed bactericidal model of action of PBT2. PBT2 has Zn2/H ionophore activity and
mediates intracellular zinc accumulation by exchanging extracellular Zn2 for intracellular 2H in an
electroneutral process. Excess zinc leads to ROS accumulation and additionally dysregulates manganese
homeostasis by inappropriately downregulating expression of the MtuABC manganese import system.
The resulting cellular manganese depletion predisposes cells to oxidative stress by limiting manganese-
dependent antioxidant activity. The manganese-dependent SodA may be inhibited by two mechanisms:
depletion of the essential manganese cofactor and zinc mismetallation. Cell death results when ROS
accumulate beyond a tolerable threshold and induce excessive oxidative damage to essential cellular
proteins and genomic DNA.
Harbison-Price et al.
March/April 2020 Volume 5 Issue 2 e00157-20 msphere.asm.org 10
 on M




























balance and ROS accumulate. Antioxidant activity is compromised under these
manganese-starved conditions, leaving the cell vulnerable to toxic O2· and H2O2.
Ferrous iron (Fe2) may potentiate this oxidative stress by reacting with H2O2 in the
Fenton reaction, generating damaging hydroxyl radicals (·OH). Extensive oxidative
damage to DNA by ·OH and to cellular proteins by O2· and H2O2 (54) ultimately proves
lethal to the bacterial cell.
Here, we have demonstrated the original intended ability of PBT2 in altering the
metallochemistry in Alzheimer’s and Huntington’s diseases can be used to destabilize
metal ion and redox homeostasis in S. uberis, sensitizing cells to oxidative stress in a
global bactericidal mechanism. Given the essentiality of manganese acquisition for S.
uberis to infect the bovine mammary gland (38) and the observed bactericidal activity
of PBT2 in bovine milk, the therapeutic potential of PBT2 as an antimicrobial for mastitis
prevention or treatment is promising. Indeed, the importance of manganese for
virulence extends to other pathogens, including S. pneumoniae, GAS, Staphylococcus
aureus, and Bacillus anthracis (27, 55–57). PBT2 represents a new class of antibacterial
capable of targeting bacterial metal ion homeostasis, and through understanding the
molecular basis of zinc ionophoric toxicity, this work serves as a platform for designing
future lead compounds with potential for veterinary-only medicine.
MATERIALS AND METHODS
Bacterial strain and growth conditions. Streptococcus uberis strain NZ01 (58) was isolated from a
clinical bovine mastitis case in the Manawatu-Wanganui region of New Zealand. S. uberis NZ01 was
grown in Todd-Hewitt broth (THB) (Sigma-Aldrich) or on THB agar (THA) containing 1.5% (wt/vol) agar
for all experiments. Bacteria were routinely grown at 37°C with agitation (200 rpm). All inoculations were
performed from overnight cultures (16 h) to a final optical density at 600 nm (OD600) of 0.05.
Chemical and radiochemical reagents. PBT2 was synthesized as described previously (29). All
stocks of PBT2 (2 mg/ml) were prepared in 100% dimethyl sulfoxide (DMSO) unless otherwise stated.
ZnSO4·7H2O (zinc) and MnSO4·H2O (manganese) stocks were prepared in filter-sterilized distilled water
(dH2O). The following radiochemicals were obtained from Moravek Inc.: [7-14C]benzoate (54.1 mCi/
mmol), [14C]methyltriphenyl phosphonium iodide (TPP) (57 mCi/mmol), [14C]polyethylene glycol 4000
(PEG), and [3H]water (1 mCi/g).
Determination of cell growth inhibition. The antibacterial activities of PBT2 and zinc, both alone
and in combination, were assessed with a checkerboard broth microdilution assay. Various concentration
combinations of PBT2 (0 to 10 mg/liter [0 to 29 M]) and zinc (0 to 800 M) were arrayed in a 96-well
flat-bottom microtiter plate and resuspended in THB inoculated with S. uberis NZ01 (OD600 of 0.05) at a
final volume of 200 l. After 24 h of incubation, cell growth (OD600) was determined by a Varioskan Flash
microplate reader (Thermo Scientific). The PBT2 and zinc MIC and CIC were determined as the lowest
concentrations that showed no visible growth. The interaction effects were derived from calculation of
the FICI, the sum of the FIC for each compound, which is in turn defined as the quotient of the MIC of
the inhibitor in combination (CIC) and the MIC of the inhibitor alone, as follows (59):
FICI  FICPBT2  FICZn   CICPBT2MICPBT2   CICZnMICZn .
FICI analysis was interpreted according to threshold values described previously (60), whereby
synergism between two inhibitors is regarded at an FICI of 0.5, antagonism at an FICI of 4.0, and no
interaction at an FICI between 0.5 and 4.0. Checkerboard assays were undertaken in biological triplicates.
For susceptibility testing of PBT2 in bovine milk, overnight cultures of S. uberis NZ01 were harvested
by centrifugation and washed twice in phosphate-buffered saline (PBS) (3,220  g for 10 min at 4°C)
before inoculation into pasteurized whole-fat (3.8%) cow milk at an OD600 of 0.1. S. uberis cells were then
inoculated 1:2 into milk containing 2-fold serial dilutions of PBT2 with various concentrations of Zn in a
96-well flat-bottom microtiter plate. After a 24-h incubation at 37°C, 10-l aliquots were spot plated on
THA plates according to the Miles-Misra drop plate method (61). Bactericidal activity was examined after
24 h of incubation at 37°C, in which a 3-log10 reduction in CFU/ml was determined as bactericidal. As
a measure of sterility, the absence of CFU in uninoculated milk was verified by plating on THA.
Bacterial time-dependent cell killing assays. S. uberis NZ01 was inoculated at an OD600 of 0.05 in
THB only, THB containing the MIC of PBT2 (5.0 mg/liter) or zinc (800 M), or THB containing a CIC of PBT2
and zinc (0.5 mg/liter PBT2 and 10 M zinc) in biological triplicates. Aliquots of cultures were taken at 0,
2, 4, 6, and 24 h postchallenge, serially diluted in 1 phosphate-buffered saline (PBS), and spot plated
on THA plates. The surviving CFU/ml of cultures was determined after a 24-h incubation at 37°C.
Examination of resistance development. Serial passaging experiments to generate resistance to
PBT2Zn/antibiotics were undertaken as described in Bohlmann et al. (29). Broth (THB) 2-fold microdi-
lution assays of PBT2 in the presence of 100 M Zn, ciprofloxacin, and rifampin were first set up in a
96-well flat-bottom microtiter plate with an initial inoculum of S. uberis NZ01 at an OD600 of 0.05. Cells
from the highest PBT2Zn or antibiotic concentrations that showed growth after 24 h of incubation
were subcultured in a new microtiter plate with 2-fold dilutions of PBT2Zn or antibiotics. Serial
passaging was repeated for 30 days in biological duplicates.
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Inductively coupled plasma mass spectrometry. Overnight cultures of S. uberis were diluted to an
OD600 of 0.05 in THB and grown to mid-log phase (OD600 of 0.3). Aliquots (45 ml) of mid-log-phase cells
were separated into individual flasks and challenged for 1 h with PBT2 (0.25, 0.5, or 1.0 mg/liter) with or
without zinc (100 M) or untreated. Samples were prepared for ICP-MS analysis according to the protocol
used by Bohlmann et al. (29). The metal contents of samples were determined using an Agilent 7500ce
ICP-MS (Centre for Trace Element Analysis, Department of Chemistry, University of Otago). Three
biological replicates were analyzed. For analysis of THB, a 2-ml aliquot of the medium was sent for
analysis.
Metal ion concentrations (milligrams/liter) of samples were converted to molar units, whereby the
intracellular metal ion concentrations of bacterial samples were calculated from the S. uberis NZ01
protein content (111 mg protein/OD600/liter) and internal cell volume (3.76 
 0.78 l/mg protein).
Protein content was determined by a bicinchoninic acid (BCA) assay, and the internal cell volume was
estimated from the difference between the intracellular and extracellular partitioning of 3H2O and the
nonmetabolizable [14C]PEG, as in a previously described method (62).
Transmembrane pH and membrane potential measurements. Overnight cultures of S. uberis were
diluted to an OD600 of 0.1 in THB (50 ml) at pH 7.5 and grown to an OD600 between 0.5 and 1.0. For ΔpH
experiments, cells were harvested by centrifugation (3,220  g for 20 min at 4°C), washed twice in THB
(pH 5.0), and resuspended to an OD600 of 1.0. For Δ experiments, cells were harvested under the same
centrifugation conditions and then resuspended to an OD600 of 1.0 in THB (pH 7.5). In both experiments,
cultures were then energized by incubating with glucose (20 mM) for 1 h at 37°C and 200 rpm. Aliquots
of energized cells were either untreated or treated with membrane-permeabilizing toluene (0.4%
[vol/vol]) or PBT2Zn at 1 or 10 the CIC (0.5 mg/liter PBT2  10 M zinc) for a further 20 min (37°C,
200 rpm). Following this, 1-ml aliquots were incubated in glass tubes with either [7-14C]benzoate (11 M
final concentration) or [14C]TPP (5 nM final concentration) for 5 min at 37°C. Radioisotope measure-
ments and calculations of the ΔpH and Δ were performed as previously described (62). Assays were
undertaken in biological triplicates.
Preparation of pyranine-containing liposomes. Pyranine-containing liposomes were prepared
according to the previously described method by Hards et al. (16). Liposomes were prepared in an
incorporation buffer (5 mM MES [morpholineethanesulfonic acid]-MOPS [morpholinepropanesulfonic
acid]-Tris in required proportions for desired pH) with or without zinc sulfate (1 mM).
Quantification of internal pH by pyranine fluorescence. The internal pH of liposomes was
measured as previously described (16). A standard curve of the pyranine fluorescence ratio to pH was
determined for each incorporation buffer, in the presence of 0.5 M pyranine, at known pH values.
Kinetic traces were measured on a Varioskan Flash plate reader (Thermo Scientific), and data were
presented from the 15-min endpoint measurements. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP;
1 M) equilibrated the internal pH of liposome preparations with the external pH (Fig. S8), confirming the
responsiveness of our preparations to pH gradients.
Isothermal titration calorimetry. ITC (isothermal titration calorimetry) experiments were performed
at 30°C with continuous stirring using a VP-ITC (GE Healthcare). ZnSO4·7H2O (zinc) and PBT2 were
dissolved in 100 mM MOPS-Tris buffer (pH 7.7, 1% DMSO). The zinc sample (0.3 mM) was injected
(30  10 l) into PBT2 (0.035 mM), and the data were analyzed using Origin 7 software and fitted to a
single site-binding model.
RNA extraction and real-time PCR. Biological triplicates of S. uberis NZ01 cells were grown to
mid-log phase (OD600 of 0.3) in THB (45 ml) and treated for 1 h with either PBT2 (1.0 mg/liter), zinc
(100 M), PBT2 and zinc combined, or untreated. Total RNA was isolated using TRIzol-chloroform
extraction as described previously (63) and purified using the RNA clean and concentrator-5 extraction
kit (ZYMO research). Following elution of RNA into DNase/RNase-free H2O, RNA was DNase treated using
the TURBO DNA-free kit (Invitrogen) according to the manufacturer’s instructions, and RNA was quan-
tified on a NanoDrop instrument (Thermo Scientific).
cDNA for each sample was synthesized using a SuperScript III reverse transcriptase kit (Invitrogen).
Primers used for quantitative PCR (qPCR) were designed on Primer-BLAST and are detailed in Table S2
in the supplemental material. Primer optimization and efficiency assays were performed, and qPCR
experiments were conducted in a ViiA7 real-time PCR system (Applied Biosystems) using the PowerUp
SYBR green master mix (Applied Biosystems) according to the manufacturer’s instructions. Results were
normalized to the gene pflC using the threshold cycle (ΔΔCT) method (64).
SOD activity assays. Overnight cultures were inoculated to an OD600 of 0.05 in THB and grown to
an OD600 of 0.3. Cultures were split into 50-ml aliquots and treated for 1 h with PBT2 (1.0 mg/liter), zinc
(100 M), or manganese (800 M), individually or in combination, or were untreated. Cultures were then
harvested by centrifugation (3,220  g for 10 min at 4°C), washed with HEPES buffer (50 mM, pH 7.4),
resuspended in 1 ml of HEPES buffer, and lysed mechanically by bead beating three times (48,000 rpm,
30 s). Lysates were centrifuged (17,000  g, 2 min, 4°C) and assayed for SOD activity using a SOD assay
kit (Invitrogen) according to the manufacturer’s instructions. Protein concentrations in the lysates were
determined by a BCA assay, and SOD activity was normalized for total protein content.
H2O2 measurement. H2O2 was measured using the Amplex Red hydrogen peroxide/peroxidase
assay kit (Invitrogen) according to the manufacturer’s instructions. An overnight culture of S. uberis cells
was diluted to an OD600 of 0.05 in THB and grown to mid-log phase (OD600 of 0.3). Mid-log-phase cells
were separated into aliquots (10 ml) and were treated for 1 h with PBT2 (1.0 mg/liter), zinc (100 M), or
manganese (800 M), individually or in combination, H2O2 (1 mM), or untreated. Cells were then
harvested by centrifugation (3,220  g for 7 min at 4°C). Cell pellets were washed twice in PBS under the
same centrifugation conditions and resuspended in 1 reaction buffer at an OD600 of 	3.5. For analysis,
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samples were diluted to an OD600 of 	0.4 in 1 reaction buffer and Amplex Red reagent/horseradish
peroxidase (HRP) working solution in a black-walled, clear-bottomed 96-well microplate. Amplex Red
fluorescence was then measured using a Varioskan Flash microplate reader at excitation and emission
wavelengths (ex and em) of 560 and 590 nm, respectively.
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